Giorgos K Sakkas1,2, Christoforos D Giannaki3, Christina Karatzaferi4,5, Mauro Manconi6,7. 1. School of Physical Education and Sport Science, University of Thessaly, Trikala, Greece. gksakkas@gmail.com. 2. Faculty of Sport, Health and Wellbeing, Plymouth Marjon University, Plymouth, PL6 8BH, UK. gksakkas@gmail.com. 3. Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus. 4. School of Physical Education and Sport Science, University of Thessaly, Trikala, Greece. 5. Faculty of Sport, Health and Wellbeing, Plymouth Marjon University, Plymouth, PL6 8BH, UK. 6. Sleep and Epilepsy Center, Neurocenter of Southern Switzerland, Civic Hospital (EOC) of Lugano, Lugano, Switzerland. 7. Neurology Department Inselspital, Bern University Hospital, Bern, Switzerland.
Abstract
PURPOSE OF REVIEW: This review summarizes the most well-documented sleep disorders seen in patients with multiple sclerosis (MS), with a special focus on the impact on quality of life. RECENT FINDINGS: Sleep abnormalities in patients with MS are a multifactorial and relatively complex issue affecting approximately 60% of the patients while the pathophysiology of these symptoms is not fully understood. Circadian rhythm disorders and increased levels of pro-inflammatory cytokines have been recognized as potential players in affecting sleep homeostasis in MS patients. Medication-related side effects such as in immunotherapy and other factors such as lesion load can contribute to the disruption of normal sleep patterns. Most frequently encountered sleep disorders are insomnia, sleep-related movement disorders, sleep-related breathing disorders, and circadian rhythm disorders affecting both adults and paediatric MS populations. Aetiology still remains unknown with treatment options focusing on behavioural cognitive therapy and lifestyle modification including improvement in sleep hygiene as well as melatonin supplementation. Given MS prevalence is still rising affecting millions of people, more personalized medicine applications should possibly form the key approach for improving patients' quality of life and quality years.
PURPOSE OF REVIEW: This review summarizes the most well-documented sleep disorders seen in patients with multiple sclerosis (MS), with a special focus on the impact on quality of life. RECENT FINDINGS:Sleep abnormalities in patients with MS are a multifactorial and relatively complex issue affecting approximately 60% of the patients while the pathophysiology of these symptoms is not fully understood. Circadian rhythm disorders and increased levels of pro-inflammatory cytokines have been recognized as potential players in affecting sleep homeostasis in MS patients. Medication-related side effects such as in immunotherapy and other factors such as lesion load can contribute to the disruption of normal sleep patterns. Most frequently encountered sleep disorders are insomnia, sleep-related movement disorders, sleep-related breathing disorders, and circadian rhythm disorders affecting both adults and paediatric MS populations. Aetiology still remains unknown with treatment options focusing on behavioural cognitive therapy and lifestyle modification including improvement in sleep hygiene as well as melatonin supplementation. Given MS prevalence is still rising affecting millions of people, more personalized medicine applications should possibly form the key approach for improving patients' quality of life and quality years.
Entities:
Keywords:
Circadian; Fatigue; Immune-mediated diseases; Melatonin; Quality of life; Survival
Authors: G Merlino; L Fratticci; C Lenchig; M Valente; D Cargnelutti; M Picello; A Serafini; P Dolso; G L Gigli Journal: Sleep Med Date: 2008-01-22 Impact factor: 3.492
Authors: Katie L J Cederberg; Brenda Jeng; Jeffer E Sasaki; E Morghen Sikes; Stephanie L Silveira; Gary Cutter; Robert W Motl Journal: Mult Scler Relat Disord Date: 2021-08-08 Impact factor: 4.808
Authors: James F Sumowski; Sam Horng; Rachel Brandstadter; Stephen Krieger; Victoria M Leavitt; Ilana Katz Sand; Michelle Fabian; Sylvia Klineova; Robin Graney; Claire S Riley; Fred D Lublin; Aaron E Miller; Andrew W Varga Journal: Ann Clin Transl Neurol Date: 2021-05-05 Impact factor: 4.511
Authors: Katie L J Cederberg; Brenda Jeng; Jeffer E Sasaki; E Morghen Sikes; Gary Cutter; Robert W Motl Journal: Disabil Health J Date: 2021-06-11 Impact factor: 4.615
Authors: Stephanie L Silveira; Katie L J Cederberg; Brenda Jeng; E Morghen Sikes; Brian M Sandroff; Catherine D Jones; Robert W Motl Journal: Qual Life Res Date: 2020-11-05 Impact factor: 4.147
Authors: Stephanie L Silveira; Katie L J Cederberg; Brenda Jeng; E Morghen Sikes; Brian M Sandroff; Catherine D Jones; Robert W Motl Journal: Disabil Health J Date: 2021-06-29 Impact factor: 4.615